171 related articles for article (PubMed ID: 32773467)
1. Atherosclerosis: cell biology and lipoproteins.
Getz GS; Reardon CA
Curr Opin Lipidol; 2020 Oct; 31(5):286-290. PubMed ID: 32773467
[TBL] [Abstract][Full Text] [Related]
2. Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis.
Stancu CS; Toma L; Sima AV
Cell Tissue Res; 2012 Aug; 349(2):433-46. PubMed ID: 22592627
[TBL] [Abstract][Full Text] [Related]
3. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
Yoshida H
Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
[TBL] [Abstract][Full Text] [Related]
4. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
5. Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD.
Taskinen MR; Packard CJ; Borén J
Curr Atheroscler Rep; 2019 May; 21(8):27. PubMed ID: 31111320
[TBL] [Abstract][Full Text] [Related]
6. The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans.
Borén J; Packard CJ; Taskinen MR
Front Endocrinol (Lausanne); 2020; 11():474. PubMed ID: 32849270
[TBL] [Abstract][Full Text] [Related]
7. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.
Camont L; Lhomme M; Rached F; Le Goff W; Nègre-Salvayre A; Salvayre R; Calzada C; Lagarde M; Chapman MJ; Kontush A
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2715-23. PubMed ID: 24092747
[TBL] [Abstract][Full Text] [Related]
8. Human ATP-binding cassette G1 controls macrophage lipoprotein lipase bioavailability and promotes foam cell formation.
Olivier M; Tanck MW; Out R; Villard EF; Lammers B; Bouchareychas L; Frisdal E; Superville A; Van Berkel T; Kastelein JJ; Eck MV; Jukema JW; Chapman MJ; Dallinga-Thie GM; Guerin M; Le Goff W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2223-31. PubMed ID: 22772754
[TBL] [Abstract][Full Text] [Related]
9. [Lipid metabolism in atherogenesis].
Bobková D; Poledne R
Cesk Fysiol; 2003 Feb; 52(1):34-41. PubMed ID: 12693188
[TBL] [Abstract][Full Text] [Related]
10. Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages.
Park SH; Kim JL; Kang MK; Gong JH; Han SY; Shim JH; Lim SS; Kang YH
Int J Mol Med; 2012 Nov; 30(5):1105-12. PubMed ID: 22922992
[TBL] [Abstract][Full Text] [Related]
11. Oxysterols in Vascular Cells and Role in Atherosclerosis.
Luquain-Costaz C; Delton I
Adv Exp Med Biol; 2024; 1440():213-229. PubMed ID: 38036882
[TBL] [Abstract][Full Text] [Related]
12. The Role of (Modified) Lipoproteins in Vascular Function: A Duet Between Monocytes and the Endothelium.
Schnitzler JG; Dallinga-Thie GM; Kroon J
Curr Med Chem; 2019; 26(9):1594-1609. PubMed ID: 29546830
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway.
Sehayek E; Eisenberg S
J Biol Chem; 1991 Sep; 266(27):18259-67. PubMed ID: 1917954
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.
Takahashi S
J Atheroscler Thromb; 2017 Jun; 24(6):552-559. PubMed ID: 28428482
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
Wassef H; Bissonnette S; Dufour R; Davignon J; Faraj M
J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
[No Abstract] [Full Text] [Related]
18. Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Endothelial Cells Accelerates Atherosclerosis in Mice.
Westerterp M; Tsuchiya K; Tattersall IW; Fotakis P; Bochem AE; Molusky MM; Ntonga V; Abramowicz S; Parks JS; Welch CL; Kitajewski J; Accili D; Tall AR
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1328-37. PubMed ID: 27199450
[TBL] [Abstract][Full Text] [Related]
19. Extracellular phospholipases in atherosclerosis.
Karabina SA; Gora S; Atout R; Ninio E
Biochimie; 2010 Jun; 92(6):594-600. PubMed ID: 20153800
[TBL] [Abstract][Full Text] [Related]
20. [THE LIPOLYSIS IN PHYLOGENETICALLY EARLY LIPOPROTEINS OF LOW DENSITY AND MORE LATER LIPOPROTEINS OF VERY LOW DENSITY: FUNCTION AND DIAGNOSTIC VALUE OF APOE AND APOC-III].
Rozhkova TA; Titov VN; Amelyushkina VA; Kaba SI; Kukhartchuk VV
Klin Lab Diagn; 2015 Dec; 60(12):4-14. PubMed ID: 27032246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
